Daniel Mendoza, DPM
Foot & Ankle Surgery · Hendersonville, TNNPI 1902883465
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Catalyst Pharmaceuticals, Inc. accounts for 67.0% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $4,925 and has fallen 99.0% since, to $48 in 2025.
Across 35 payments — averaging $195.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Catalyst Pharmaceuticals, Inc.$5K
- Paragon 28, Inc.$1K
- Stryker$683
- Progenacare Global, LLC$241
- Averitas Pharma Inc.$95
- Crossroads Extremity Systems, LLC$42
- plus $141 from 6 others
What the payments were for
- Speaking & faculty fees$3,50051%
- Travel & lodging$1,75326%
- Food & beverage$1,59023%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Catalyst Pharmaceuticals, Inc. | 7 | $4,584 |
| Paragon 28, Inc. | 2 | $1,057 |
| Stryker | 14 | $683 |
| Progenacare Global, LLC | 1 | $241 |
| Averitas Pharma Inc. | 4 | $95 |
| Crossroads Extremity Systems, LLC | 1 | $42 |
| Johnson & Johnson | 1 | $31 |
| Amgen | 1 | $29 |
| Treace Medical Concepts, Inc. | 1 | $26 |
| NS Pharma, Inc. | 1 | $24 |
| Abbott | 1 | $16 |
| Nevro Corp. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AGAMREE$4,376
- Product Portfolio$987
- EASYFUSE$134
- CHARLOTTE$134
- ORTHOLOC 2 LAPIFUSE$134
- AUGMENT INJECTABLE$134
- N/A$129
How this compares
$6,843 in reported general payments places this provider in the 65th percentile of 145 foot & ankle surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 19 | $315 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 41 | $275 |
| Gabapentin | 15 | $183 |
| Doxycycline Hyclate | 22 | $169 |
| Methylprednisolone | 14 | $90 |
| Ibuprofen | 13 | $62 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Hendersonville
- Bryan LapinskiHendersonville$9K
- Sebastien DemoinyMorristown$210K
- Robert ThompsonMurfreesboro$205K
- Bhekumuzi KhumaloUnion City$201K
- Walter ButlerMemphis$191K
- Chad WebsterCordova$185K
- Christian SmithCordova$153K
- Frank OgnibeneMemphis$148K
- Garnett MurphyGermantown$130K
- Clayton BettinMemphis$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.